SkyePharma License Marketing and Distribution Rights for DepoCyte® to Mundipharma
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 39 (Table of Contents)
Published: 1 Aug-2003
DOI: 10.3833/pdr.v2003.i39.877 ISSN: 1756-7874
Section: Distribution & Marketing
Fulltext:
Abstract
SkyePharma and Mundipharma entered into licensing agreement for marketing and distribution rights to SkyePharma’s DepoCyte® (cytarabine) for treating lymphomatous meningitis...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS